Apnicaf Injection
Prescription Required
Product introduction
Apnicaf Injection is a prescription medicine used in the treatment of apnea (a disorder in which breathing repeatedly stops and starts) of prematurity. It facilitates normal breathing and reduces interrupted breathing in premature newborns.
It is used in migraine.
It is used in migraine.
Uses of Apnicaf Injection
- Apnea of prematurity
Benefits of Apnicaf Injection
In Apnea of prematurity
In a premature baby, the part of the brain that controls breathing is not mature enough for nonstop breathing. This causes large bursts of breath followed by periods of shallow breathing or stopped breathing. This is called apnea or breathing trouble of prematurity. Apnicaf Injection helps to stimulate those areas of the brain that control breathing and normalise it. It is given as an injection by a doctor or nurse.
Side effects of Apnicaf Injection
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if youโre worried about them
Common side effects of Apnicaf
- Delirium (acute confusional state)
- Insomnia (difficulty in sleeping)
- Frequent urge to urinate
- Dehydration
- Fever
How to use Apnicaf Injection
Your doctor or nurse will give you this medicine. Kindly do not self administer.
How Apnicaf Injection works
Apnicaf Injection is a stimulant. It works by blocking the action of certain natural substances (adenosine and phosphodiesterase) leading to stimulation of the brain and respiratory system in premature newborns. This reduces the number of episodes of interrupted breathing and helps the newborns breathe on their own.
Safety advice
Alcohol
UNSAFE
It is unsafe to consume alcohol with Apnicaf Injection.
Pregnancy
CONSULT YOUR DOCTOR
Apnicaf Injection may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Breast feeding
CAUTION
Apnicaf Injection should be used with caution during breastfeeding. Breastfeeding should be held until the treatment of the mother is completed and the drug is eliminated from her body.
Driving
UNSAFE
Apnicaf Injection may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Kidney
CONSULT YOUR DOCTOR
There is limited information available on the use of Apnicaf Injection in patients with kidney disease. Please consult your doctor.
Liver
CONSULT YOUR DOCTOR
There is limited information available on the use of Apnicaf Injection in patients with liver disease. Please consult your doctor.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
No substitutes found for this medicine
Quick tips
- Apnicaf Injection helps in the treatment of interrupted breathing in premature babies.
- It is given as an injection (drip) by your doctor or nurse.
- If you are breast-feeding while your infant is treated with Apnicaf Injection, do not drink coffee or take any other high caffeine product as caffeine passes into breast milk.
Fact Box
Chemical Class
Xanthine Derivative
Habit Forming
No
Therapeutic Class
CARDIAC
Action Class
Adenosine receptor (A1 & A2) antagonist
Patient concerns
User feedback
What are you using Apnicaf Injection for?
Others
100%
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- OโBrien CP. Drug Addiction. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilmanโs: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. p. 663.
- Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 179-83.
Marketer details
Name: Abbott
Address: 16th Floor, Godrej BKC, Plot โ C, โGโ Block, Bandra-Kurla Complex, Bandra (East), Mumbai โ 400 051, India
Country of origin: India
Lab tests offered by us
Related/Popular tests
MRP
โน764.89
Inclusive of all taxes
3.0 ml in 1 vial
SOLD OUT